rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACGGGGAGACCCAGTACTTCGGGCCA	CASSHGETQYF	In	VDJ	1	64	0.003979604526800149	0.005019607843137255	33	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	5	0	0	29	-1	-1	43	47						01,02							Vb 16	CASSHGETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCGATTTTAGGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	66	0.004103967168262654		40	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-05	01	4	5	4	7	8	1	29	42	53	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01		TCRBJ01-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTCCGGGGGCGGGATGGCTACACCTTCGGTTCG	CASSQDLRGRDGYTF	In	VDJ	1	186	0.011565725656012934	0.014588235294117647	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	0	6	0	6	5	3	29	46	57	51	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDLRGRDGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCACCGCCGCAGGGAAGGCACTTGGCTACACCTTCGGTTCG	CATAAGKALGYTF	In	VDJ	1	46	0.0028603407536376075	0.003607843137254902	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	3	7	6	8	24	31	42	37	50														CATAAGKALGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATGTGGCTAGGCTACACTTTCTCTGAGACCCAGTACTTCGGGCCA	CASSMWLGYTFSETQYF	In	VDJ	2	263	0.016353687352319363	0.02062745098039216	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	8	5	5	14	24	37	46	42	60						01,02								CASSMWLGYTFSETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCAAGGACTAGCGGGAGGGGCGATGAGCAGTTCTTCGGGCCA	CASSSRTSGRGDEQFF	In	VDJ	1	100	0.006218132073125233	0.00784313725490196	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	0	8	3	3	19	32	50	35	53														CASSSRTSGRGDEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCGCGGGATCCATCTCTGGAAACACCATATATTTTGGAGAG	CASSEAAGSISGNTIYF	In	VDJ	1	41	0.0025494341499813456	0.003215686274509804	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	7	3	0	1	5	23	40	47	41	52														CASSEAAGSISGNTIYF+TCRBV06-01+TCRBJ01-03	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGACCTGGCACTGGAAACACCATATATTTTGGAGAG	CAWRGPGTGNTIYF	In	VDJ	1	70	0.004352692451187664	0.005490196078431373	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	3	0	7	2	0	6	26	-1	42	37	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRGPGTGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGACAGGGGCCCTGAAGCTTTCTTTGGACAA	CAWSGDRGPEAFF	In	VDJ	1	142	0.008829747543837831	0.011137254901960785	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	2	6	2	2	26	39	49	41	51			unresolved										Vb 20	CAWSGDRGPEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGAATGGGGGAGCATCGCGAGCAGTACTTCGGGCCG	CAWSVGMGEHREQYF	In	VDJ	3	380	0.023628901877875887	0.02980392156862745	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	0	6	1	6	6	7	26	40	51	46	58			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGMGEHREQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCCCCCTAGGCCTTCCGGAGGGGAGCAGTTCTTCGGGCCA	CASSQDPPRPSGGEQFF	In	VDJ	1	109	0.006777763959706504	0.008549019607843137	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	0	10	16	0	23	40	-1	56	62														CASSQDPPRPSGGEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTCCCCGGGACTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASRSPGLSNQPQHF	In	VDJ	1	41	0.0025494341499813456	0.003215686274509804	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	0	10	0	6	0	25	36	-1	42	48						01,02							Vb 3	CASRSPGLSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCCCGGGACAGGGGTCTATGGCTACACCTTCGGTTCG	CASTPGTGVYGYTF	In	VDJ	1	61	0.003793060564606392	0.004784313725490196	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	4	5	1	25	35	50	40	51													Vb 3	CASTPGTGVYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGGGTAGCGGAAACACCATATATTTTGGAGAG	CASSFGGSGNTIYF	In	VDJ	1	62	0.0038552418853376445	0.0048627450980392155	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	3	6	1	4	1	4	25	39	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFGGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTTCCCAGCGGGGACATTATAAGAGTAGCAATGAGCAGTTCTTCGGGCCA	CASSLSSQRGHYKSSNEQFF	In	VDJ	1	106	0.0065912199975127475	0.00831372549019608	60	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	3	6	6	15	21	37	50	43	65													Vb 3	CASSLSSQRGHYKSSNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCCGAGCATTGAAACAGGGGGATCCCTACGAGCAGTACTTCGGGCCG	CARALKQGDPYEQYF	In	VDJ	1	112	0.006964307921900261	0.008784313725490196	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	3	1	2	11	3	25	31	50	42	53													Vb 3	CARALKQGDPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCTAACTATGGCTACACCTTCGGTTCG	CASSLANYGYTF	In	VJ	1	137	0.00851884094018157	0.010745098039215686	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	2	0	0	0	0	1	25	-1	40	-1	41													Vb 3	CASSLANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACAGCGGCCGTTCAGTTCTTCGGGCCA	CASSLTAAVQFF	In	VDJ	2	226	0.014052978485263027	0.01772549019607843	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	5	13	2	5	25	40	47	42	52						01,02							Vb 3	CASSLTAAVQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGGGACAAATGAACACTGAAGCTTTCTTTGGACAA	CASSLGQMNTEAFF	In	VDJ	2	253	0.01573187414500684	0.01984313725490196	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	2	2	25	37	45	39	47													Vb 3	CASSLGQMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAATCGGACTAGCGGGCGACCCAATAAAGAGACCCAGTACTTCGGGCCA	CASNRTSGRPNKETQYF	In	VDJ	1	117	0.007275214525556523	0.009176470588235295	51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	1	4	3	4	10	18	27	42	31	52						01,02								CASNRTSGRPNKETQYF+TCRBV12-02+TCRBJ02-05	TCRBV12-02*01	TCRBD02-01	TCRBJ02-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCTTCAGATTCCGAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	69	0.004290511130456411		55	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	13	5	22	34	52	47	57														X+TCRBV07-01+TCRBJ02-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACCAGACAGGGAGGGGCCTCTACGAGCAGTACTTCGGGCCG	CASSDQTGRGLYEQYF	In	VDJ	1	116	0.00721303320482527	0.009098039215686275	48	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	3	2	3	3	3	8	23	37	47	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDQTGRGLYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCTGACAGGGGACATATATTCACCCCTCCACTTTGGGAAC	CASSLTGDIYSPLHF	In	VDJ	1	119	0.007399577167019027	0.009333333333333334	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	2	8	3	6	23	34	45	37	51													Vb 12	CASSLTGDIYSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGGGCTAGCGGTAGTGACGGGGAGCTGTTTTTTGGAGAA	CAIRASGSDGELFF	In	VDJ	1	48	0.002984703395100112	0.0037647058823529413	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	5	7	2	6	24	35	44	37	50						01,02							Vb 12	CAIRASGSDGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACAGCTTTCTATCTCTGTGCCAGTAGTATCCCAAATCCAGTCTCGTCGCCCCCCTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	47	0.0029225220743688595		59	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	5	4	8	16	16	30	41	38	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGCGGGAGGTTCGGTTCTACAATGAGCAGTTCTTCGGGCCA	CASRGREVRFYNEQFF	In	VDJ	1	69	0.004290511130456411	0.005411764705882353	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	1	3	3	7	27	38	49	41	56			01,02										Vb 17	CASRGREVRFYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTCCATGGGGGCGCTACAGATACGCAGTATTTTGGCCCA	CASTLHGGATDTQYF	In	VDJ	1	119	0.007399577167019027	0.009333333333333334	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	6	0	3	8	3	27	37	51	45	54			01,02										Vb 17	CASTLHGGATDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCTAAGCTCCAGTGGGGTTTCGGTTGGCTACACCTTCGGTTCG		Out	VDJ	1	121	0.007523939808481532		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	10	6	2	7	13	7	27	34	51	47	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCTGAAGGGGGCGGGGAGCTGTTTTTTGGAGAA	CASRAEGGGELFF	In	VDJ	1	141	0.00876756622310658	0.011058823529411765	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	5	1	7	6	0	27	38	-1	44	50			01,02										Vb 17	CASRAEGGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCTACCGGCGCGGCTCACTGAAGCTTTCTTTGGACAA	CASSSLPARLTEAFF	In	VDJ	1	151	0.009389379430419103	0.01184313725490196	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	5	4	10	2	27	40	54	50	56			01,02			01,02							Vb 17	CASSSLPARLTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTNTGELFF	In	VDJ	1	158	0.009824648675537869	0.012392156862745097	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	4	6	0	0	0	27	-1	-1	35	37			01,02										Vb 17	CASTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCTTCTGAAGCTTTCTTTGGACAA	CASSISSEAFF	In	VDJ	1	179	0.011130456410894168	0.01403921568627451	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	4	10	6	1	1	27	42	45	43	46			01,02			01,02							Vb 17	CASSISSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACTAATTCCTACGAGCAGTACTTCGGGCCG	CASSITNSYEQYF	In	VDJ	2	210	0.01305807735356299	0.01647058823529412	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	9	1	0	2	27	-1	46	42	48			01,02			01,02							Vb 17	CASSITNSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGACAGCCATACCCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIRTAIPYSGANVLTF	In	VDJ	2	231	0.014363885088919288	0.01811764705882353	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	1	5	0	1	10	24	39	46	40	56			01,02										Vb 17	CASSIRTAIPYSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTATAACACTAGCGGGAGTTGGCATACGCAGTATTTTGGCCCA		Out	VDJ	2	288	0.01790822037060067		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	3	2	7	10	5	27	37	58	47	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTACACGTACTGAACACTGAAGCTTTCTTTGGACAA	CASSLHVLNTEAFF	In	VDJ	2	293	0.018219126974256934	0.022980392156862744	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	3	6	0	3	5	27	38	44	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLHVLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAGGCTACACTGAAGCTTTCTTTGGACAA	CASSIGGYTEAFF	In	VDJ	2	297	0.018467852257181942	0.023294117647058823	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	3	1	2	27	41	47	42	49			01,02										Vb 17	CASSIGGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATTCTGTATAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	116	0.00721303320482527		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	6	5	12	5	23	37	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTTATGGGGCCCTTGGGAGGCAGGCTACGAGCAGTACTTCGGGCCG	CSVEDLWGPWEAGYEQYF	In	VDJ	1	42	0.002611615470712598	0.0032941176470588237	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	1	3	14	4	25	39	59	53	63													Vb 4	CSVEDLWGPWEAGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAGCCTAGGGGGTTTGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	109	0.006777763959706504		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	5	1	5	5	4	25	37	48	42	52													Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGACTAGCGGGGGCCAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	41	0.0025494341499813456		52	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	2	0	1	3	26	39	54	40	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TGTGCCAGCAGCTTTTTCCCATGGGATGGACTAGCGGTAAGGGCCAACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	0.002611615470712598		70	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	5	0	13	12	-1	13	36	26	48	TCRBV05,TCRBV07					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCAGGGACTAGCACAGAGACCCAGTACTTCGGGCCA	CASSPGTSTETQYF	In	VDJ	1	44	0.0027359781121751026	0.0034509803921568627	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	7	4	3	2	18	30	42	33	44	TCRBV07,TCRBV11					01,02								CASSPGTSTETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGGGAGGGGCGACTATGGCTACACCTTCGGTTCG	CSAQGRGDYGYTF	In	VDJ	1	46	0.0028603407536376075	0.003607843137254902	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	0	3	3	3	26	35	45	38	48		TCRBV20-01,TCRBV20-or09_02												CSAQGRGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GGACKCRGCCMTSTAYCTSTGTGCCAGCAGCCCATATGTCGGGAGCTCCTACAGTGAGCAGTTCTTCGGGCCA	CASSPYVGSSYSEQFF	In	VDJ	1	46	0.0028603407536376075	0.003607843137254902	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	9	8	9	19	31	45	39	54	TCRBV05,TCRBV15													CASSPYVGSSYSEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTCCCACAGGGAACCTACGAGCAGTACTTCGGGCCG	CSALPQGTYEQYF	In	VDJ	1	48	0.002984703395100112	0.0037647058823529413	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	2	6	2	26	34	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSALPQGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTATTTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLFSGNTGELFF	In	VDJ	1	48	0.002984703395100112	0.0037647058823529413	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	5	1	2	0	18	33	-1	35	41	TCRBV05,TCRBV11					01,02								CASSLFSGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TGGGSGACTCRGCTKTGTATYTCTGTGCCAGCAGCTCTCAGCATCGAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSSQHRGQSRANVLTF	In	VDJ	1	49	0.0030468847158313644	0.0038431372549019606	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	6	5	11	5	19	32	48	43	53	TCRBV07,TCRBV09													CASSSQHRGQSRANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGTCGGGGAGGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEVGEAPYNEQFF	In	VDJ	1	49	0.0030468847158313644	0.0038431372549019606	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	1	2	5	3	18	35	46	40	49	TCRBV07,TCRBV11													CASSLEVGEAPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCAACGGGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	51	0.003171247357293869		37	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	3	2	6	0	26	34	-1	40	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGYGACTCKGCTGTGTATYTCTGTGCCAGCAGCAACGAAATCCGACAGGGAAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	55	0.003419972640218878		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	4	10	2	26	38	55	48	57	TCRBV03,TCRBV07													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGACAGGGTCCAACACCGGGGAGCTGTTTTTTGGAGAA	CSARATGSNTGELFF	In	VDJ	1	55	0.003419972640218878	0.004313725490196078	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	3	2	1	3	26	39	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSARATGSNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAACTACAGGGTACCGGGACTAGTGGCTACACCTTCGGTTCG	CSAKLQGTGTSGYTF	In	VDJ	1	59	0.0036686979231438876	0.004627450980392157	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	0	8	7	16	0	26	34	-1	50	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKLQGTGTSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTCTGCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	61	0.003793060564606392		47	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	16	0	26	38	-1	54	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGAAGCGGGGGGGCTCGGAATGAGCAGTTCTTCGGGCCA	CASSRSGGARNEQFF	In	VDJ	1	62	0.0038552418853376445	0.0048627450980392155	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	7	3	5	18	30	43	33	48	TCRBV07,TCRBV11													CASSRSGGARNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCGGGGCCTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFSGPSYNEQFF	In	VDJ	1	63	0.003917423206068897	0.004941176470588235	45	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	7	0	1	3	2	26	40	48	43	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGPSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAATAGAGGCCTAGCGATTGAGCAGTTCTTCGGGCCA	CASSNRGLAIEQFF	In	VDJ	1	65	0.004041785847531402	0.005098039215686275	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	6	9	9	2	24	36	51	45	53		TCRBV24-01,TCRBV24-or09_02				01,02								CASSNRGLAIEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATTTACAGGGACTAGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	66	0.004103967168262654		53	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	0	8	0	6	0	23	40	-1	46	54	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATAGGCTCTGTGAACACTGAAGCTTTCTTTGGACAA	CASSIGSVNTEAFF	In	VDJ	1	68	0.004228329809725159	0.005333333333333333	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	5	4	0	2	5	24	36	41	38	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIGSVNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCTCAACAGACAGATACGCAGTATTTTGGCCCA	CASSAQQTDTQYF	In	VDJ	1	72	0.004477055092650168	0.005647058823529412	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	5	3	6	0	26	37	-1	43	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSAQQTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTACTACGACAGGGGCGGGTGAGCAGTTCTTCGGGCCA	CASSTTTGAGEQFF	In	VDJ	1	73	0.0045392364133814206	0.005725490196078431	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	9	5	4	24	36	49	41	53	TCRBV24,TCRBV27													CASSTTTGAGEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCTAGCGGGAGGACCCTCGAAGAGTAGTACTTCGGGCCG	CSAPSGRTLEE*YF	Stop	VDJ	1	75	0.004663599054843925		42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	1	11	2	13	26	34	47	36	60		TCRBV20-01,TCRBV20-or09_02												CSAPSGRTLEE*YF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCCCGGGACAGACGAAAAACTGTTTTTTGGCAGT	CSAAPGTDEKLFF	In	VDJ	1	76	0.0047257803755751775	0.00596078431372549	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	8	6	2	26	35	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSAAPGTDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCTATAGGTCCCTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	80	0.004974505658500186		50	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	5	4	5	5	13	26	38	46	43	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGATCCGTCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	82	0.005098868299962691		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	5	17	3	26	38	58	55	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAGGACAGGGATCCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	82	0.005098868299962691		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	3	2	1	4	18	33	42	34	46	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCGGGGTTTTTACAATGAGCAGTTCTTCGGGCCA	CSARGRGFYNEQFF	In	VDJ	1	83	0.005161049620693943	0.006509803921568628	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	4	2	4	26	39	46	41	50		TCRBV20-01,TCRBV20-or09_02												CSARGRGFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSQGGNQPQHF	In	VDJ	1	87	0.005409774903618953	0.006823529411764706	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	6	1	4	0	0	26	-1	-1	42	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGCGAGACACAGGTTGGGGAAACACCATATATTTTGGAGAG	CASSRRDTGWGNTIYF	In	VDJ	1	88	0.005471956224350205	0.0069019607843137255	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	4	4	8	4	26	39	52	47	56		TCRBV03-01,TCRBV03-02												CASSRRDTGWGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAACAGGGTTATGAGCAGTTCTTCGGGCCA	CSARKQGYEQFF	In	VDJ	1	93	0.005782862828006467	0.007294117647058823	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	3	8	2	2	26	38	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSARKQGYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGTGCGGGAGGACAGGGCGAGCAGTACTTCGGGCCG	CASSQEGAGGQGEQYF	In	VDJ	1	105	0.006529038676781495	0.00823529411764706	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	1	3	6	10	0	26	43	-1	53	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGAGGQGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGATTGGCGGGAGATAACGAGCAGTACTTCGGGCCG	CASRLAGDNEQYF	In	VDJ	1	109	0.006777763959706504	0.008549019607843137	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	7	2	5	4	3	24	35	46	39	49		TCRBV24-01,TCRBV24-or09_02												CASRLAGDNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGGCGGGAGGGCCAGGAGAGCAGTTCTTCGGGCCA	CASSDSAGGPGEQFF	In	VDJ	1	109	0.006777763959706504	0.008549019607843137	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	0	10	1	6	23	40	50	41	56	TCRBV06,TCRBV10													CASSDSAGGPGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTCCTCGGGACAGGGGCCATAAAAATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	123	0.007648302449944037		55	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	3	6	10	26	39	55	45	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGACGGGTACTCGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSDGYSTGGNTEAFF	In	VDJ	1	131	0.008145753015794056	0.01027450980392157	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	1	12	0	23	34	-1	46	55	TCRBV09,TCRBV12													CASSDGYSTGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTGCAGTACGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	140	0.008705384902375327		46	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	4	5	2	6	5	26	40	49	46	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGACCGCGAGCAGTACTTCGGGCCG	CSARDQDREQYF	In	VDJ	1	143	0.008891928864569083	0.011215686274509805	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	2	7	6	4	2	26	40	47	44	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQDREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGTGTTAGTCCCATTAACATTCAGTACTTCGGCGCC	CASSSVSPINIQYF	In	VDJ	1	155	0.009638104713344111	0.01215686274509804	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	5	8	7	5	7	26	38	46	43	53		TCRBV03-01,TCRBV03-02				01,02								CASSSVSPINIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTCTCCCGGACTGGGTGACAATGAGCAGTTCTTCGGGCCA	CASSSPGLGDNEQFF	In	VDJ	1	155	0.009638104713344111	0.01215686274509804	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	5	6	5	23	35	46	41	51	TCRBV02,TCRBV12					01,02								CASSSPGLGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGCGAGGGGGCCCTCACAGATACGCAGTATTTTGGCCCA	CSARRGEGALTDTQYF	In	VDJ	1	160	0.009949011317000373	0.012549019607843137	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	0	2	7	3	26	38	52	45	55		TCRBV20-01,TCRBV20-or09_02												CSARRGEGALTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGGTCGAGCGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	XASSRSSGVNTGELFF	In	VDJ	1	160	0.009949011317000373	0.012549019607843137	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	6	3	1	5	1	23	36	48	41	49	TCRBV04,TCRBV07,TCRBV17													XASSRSSGVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGACCGACAGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRPTGGTGELFF	In	VDJ	1	167	0.010384280562119139	0.013098039215686275	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	4	4	3	3	24	35	44	38	47	TCRBV12,TCRBV21													CASRPTGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCACGAACCCTACGAGCAGTACTTCGGGCCG	CSARGHEPYEQYF	In	VDJ	1	170	0.010570824524312896	0.013333333333333334	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	2	8	2	5	2	26	39	46	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGHEPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGCCGGACTAGCGGTATACAATGAGCAGTTCTTCGGGCCA	CASSAGLAVYNEQFF	In	VDJ	1	177	0.011006093769431662	0.01388235294117647	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	4	3	2	22	34	47	37	49	TCRBV09,TCRBV12					01,02								CASSAGLAVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCTTTGTATTTCAGGCTTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	207	0.012871533391369233		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	5	12	4	26	38	54	50	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGTCGGGACAGCACAGATACGCAGTATTTTGGCCCA	CSARRDSTDTQYF	In	VDJ	2	227	0.014115159805994279	0.01780392156862745	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	0	7	0	5	0	26	34	-1	39	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRDSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGCAACGCACAGGGGGCGTCACTGAAGCTTTCTTTGGACAA	CASSQQRTGGVTEAFF	In	VDJ	2	252	0.015669692824275588	0.01976470588235294	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	4	7	2	23	37	53	44	55	TCRBV01,TCRBV04													CASSQQRTGGVTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACGACAAACGGGAGAGGGGGCCCTAATGAAAAACTGTTTTTTGGCAGT	CASTTNGRGGPNEKLFF	In	VDJ	2	328	0.020395473199850765	0.02572549019607843	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	5	0	3	13	1	23	33	53	46	54	TCRBV02,TCRBV12													CASTTNGRGGPNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCTCCTCGGGGGCTTGAGCAGTTCTTCGGGCCA	CSARDPPRGLEQFF	In	VDJ	3	340	0.021141649048625793	0.02666666666666667	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	6	0	9	8	1	26	40	54	48	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPPRGLEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAACCGAGCGGGAGGGACCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	350	0.021763462255938316		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	0	8	3	4	23	38	51	41	55	TCRBV01,TCRBV04													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCTACTCTGGAAACACCATATATTTTGGAGAG	CSARGYSGNTIYF	In	VDJ	5	609	0.03786842432533267	0.04776470588235294	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	4	9	0	1	0	26	39	-1	40	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGYSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GCAAGCCACGTTTGGTGGTCAGGAGACACAGCACRGTATTTCTGTGCCAGCAGCCCCTGGGACAGCTACGAGCAGTACTTCGGGCCG	CASSPWDSYEQYF	In	VDJ	1	41	0.0025494341499813456	0.003215686274509804	39	TCRBV21	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	4	0	24	36	-1	40	47		TCRBV21-01,TCRBV21-or09_02												CASSPWDSYEQYF+TCRBV21-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCAGCGGCTTATATAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	62	0.0038552418853376445		56	TCRBV12	TCRBV12-01	01				TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	22	34	53	48	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01		TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCAACAGGGTCAACACTGAAGCTTTCTTTGGACAA	CATSSNRVNTEAFF	In	VDJ	1	100	0.006218132073125233	0.00784313725490196	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	2	2	2	18	32	40	34	42														CATSSNRVNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAAATCTCTCCGGGTGGCTACACCTTCGGTTCG	CATSRDQISPGGYTF	In	VDJ	1	115	0.007150851884094018	0.009019607843137255	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	4	7	11	0	18	35	-1	46	50						01,02								CATSRDQISPGGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGAGTATACAGGGTCAAGCTAACTATGGCTACACCTTCGGTTCG	CATRSIQGQANYGYTF	In	VDJ	1	140	0.008705384902375327	0.010980392156862745	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	0	6	5	18	29	41	35	46														CATRSIQGQANYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGTGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CATSREWGGTDTQYF	In	VDJ	6	753	0.04682253451063301	0.05905882352941177	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	3	2	1	18	35	44	37	45														CATSREWGGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGTCAGGGGGTAGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	47	0.0029225220743688595		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	5	5	6	18	32	44	37	50														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGAGGTGCCCATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	65	0.004041785847531402		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	1	4	2	6	18	32	38	34	44														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAGACTAGGCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	86	0.0053475935828877		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	2	8	5	3	12	18	32	41	35	53						01,02								X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACCGGGACTCACAGATACGCAGTATTTTGGCCCA	CASSSPGLTDTQYF	In	VDJ	1	161	0.010011192637731625	0.012627450980392156	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	2	4	0	18	31	-1	35	41						01,02								CASSSPGLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCCCCCATCTCGCTCGGGGGGCTGAGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	85	0.005285412262156448		55	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	1	4	13	6	26	40	60	53	66														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTCTATAGACGGCCGGCTCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	201	0.01249844546698172		38	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	11	2	7	8	5	10	26	32	40	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGCAGGGGGCTTGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDSAGGLFSGANVLTF	In	VDJ	1	48	0.002984703395100112	0.0037647058823529413	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	4	0	0	2	5	23	40	50	42	55														CASSDSAGGLFSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTAGCGGGGTCACAGATACGCAGTATTTTGGCCCA	CASSFSGVTDTQYF	In	VDJ	1	51	0.003171247357293869	0.004	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	3	2	1	1	23	36	45	37	46														CASSFSGVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGGGTAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGGVDTGELFF	In	VDJ	1	61	0.003793060564606392	0.004784313725490196	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	9	0	3	0	3	23	-1	45	38	48														CASSYGGVDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAGGCACCCGATGGCTACACCTTCGGTTCG	CASRQAPDGYTF	In	VDJ	1	72	0.004477055092650168	0.005647058823529412	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	4	6	0	6	23	-1	39	34	45														CASRQAPDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGGGTCGGCGGGGGGGCCTTGAGGAGCAGTTCTTCGGGCCA	CAIGGRRGGLEEQFF	In	VDJ	1	81	0.005036686979231439	0.006352941176470588	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	7	0	10	10	7	23	30	49	40	56														CAIGGRRGGLEEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACCGATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASS*PISGANVLTF	Stop	VDJ	1	112	0.006964307921900261		45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	3	2	8	0	3	1	23	37	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*PISGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATATCACTAGCGGGGGATTAGGGAAGCAGTACTTCGGGCCG	CASSYITSGGLGKQYF	In	VDJ	1	169	0.010508643203581644	0.013254901960784314	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	8	4	8	23	37	52	41	60														CASSYITSGGLGKQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCGGGACAGGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSGTGGYNEQFF	In	VDJ	2	217	0.013493346598681757	0.017019607843137254	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	4	3	4	3	23	34	46	38	49														CASSSGTGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCGACCCCTGGAGGGCTCCGAAGCTTTCTTTGGACAA	CASNRPLEGSEAFF	In	VDJ	2	218	0.013555527919413009	0.017098039215686273	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	0	8	10	4	23	33	49	43	53														CASNRPLEGSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGTCAGCGGGGGGCGAAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	238	0.014799154334038054		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	1	7	4	5	23	37	50	41	55														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTTATGACAGGGGCCAACTACGAGCAGTACTTCGGGCCG	CASFMTGANYEQYF	In	VDJ	3	342	0.021266011690088297	0.026823529411764704	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	2	3	5	4	23	32	45	37	49														CASFMTGANYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACTATCGGGACAGCCGGGAACATTCAGTACTTCGGCGCC	CASSTIGTAGNIQYF	In	VDJ	1	82	0.005098868299962691	0.006431372549019608	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	5	7	6	5	24	36	49	42	54													Vb 18	CASSTIGTAGNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGGCGCGGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	165	0.010259917920656635		50	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	5	0	6	5	7	5	24	36	49	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCCTGCGACAGGTCAACACTGAAGCTTTCTTTGGACAA	CASSPLRQVNTEAFF	In	VDJ	1	181	0.011254819052356672	0.01419607843137255	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	2	8	2	24	35	49	43	51													Vb 18	CASSPLRQVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTGCGGGGATACGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPRAGIRSSYEQYF	In	VDJ	2	219	0.01361770924014426	0.017176470588235293	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	0	2	8	24	40	48	42	56													Vb 18	CASSPRAGIRSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGTGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGWPNTGELFF	In	VDJ	2	239	0.014861335654769308	0.018745098039215688	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	2	0	9	0	0	4	24	-1	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGWPNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	2585A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				154	122	30	1	0	119	89	28	2	0	16082	12750	3145	187	0	0.0546583198	6.12178087	0.0500660315	6.54962158				2192	0.0502511114	0.0590588227	0.046822533	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:00	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1488,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1249,treatment:nact,type of chemo:carbo/taxol	0.7922077706150426	MSKCC- Snyder- P01-01		110.0	
